Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes

A legfontosabb adatok

Ki végzi
M.D. Anderson Cancer Center
Hol
Houston (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Befejeződött
Résztvevők
169 fő vett részt
Kezdés
2022. jún. 2.
Befejezés
2026. jan. 7.
A vizsgálat típusa
Beavatkozással járó, 2 csoport
A vizsgált kezelések
  • Nicotine Replacement
  • Questionnaire Administration
  • Electronic Cigarette
A regiszteradat frissítve
2026. január 28.

Ki vehet részt

Életkor
21 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 14 feltétel megnézéseKevesebb

Ki vehet részt

  • Aged 21 years or older
  • Reports being a daily or non-daily smoker (any self-reported smoking in the past 30 days)
  • Have an address where he/she can receive mail
  • Able to follow verbal and written instructions in English and complete all aspects of the study as determined by PI
  • Willing to have urine biospecimen samples taken, either in-home and returning them by mail, or in-person at an approved collection site
  • Willing to use tobacco-flavored study electronic cigarettes
  • Agrees to comply with all MD Anderson institutional policies related to COVID-19 screening prior to any in-person research visit
  • The individual agrees to not engage in study procedures or interactions with study personnel while operating a vehicle

Ki nem vehet részt

  • Being pregnant, engaging in breast-feeding, or being of childbearing potential and engaging in sexual activity that could lead to pregnancy and is not protected by a medically acceptable, effective method of birth control while enrolled in the study, as determined by self-report. Medically acceptable contraceptives include: (1) approved hormonal contraceptives (such as birth control pills, patches, implants or injections), (2) barrier methods (such as a condom or diaphragm) used with a spermicide, or (3) an intrauterine device (IUD). Contraceptive measures sold for emergency use after unprotected sex are not acceptable methods for routine use
  • Uncontrolled or unstable medical condition (e.g., uncontrolled hypertension, angina, diabetes)
  • Individuals who report depressive symptoms in the moderately severe or severe range on the PHQ-9 (scores of 15 or above) or who report current suicidal ideation on the PHQ-9
  • Evidence of cognitive deficits or instability that would preclude reliable study participation
  • Considered by the investigator to be an unsuitable or unstable candidate (including but not limited to the following situation: unwilling or unable to comply with study procedures)
  • Individuals who reside in an area that is outside of our shipping company's area of operation or in a jurisdiction outside of our medical staff's licensure (if unable to attend in-person clinic visits) AND who decline or are unable to come in to clinic to provide necessary samples and/or collect study products

Helyszínek itt: Egyesült Államok

  • M D Anderson Cancer CenterHouston, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

This early phase I trial studies potential differences between men and women when switching from the use of combustible cigarettes to the National Institute on Drug Abuse's Standard Research E-Cigarette (SREC). Studying the differences between men and women may increase understanding about the effects of switching from smoking regular cigarettes to electronic cigarettes.

A vizsgálat 2 csoportja

  • E-Cig placebo dose followed by E-Cig nicotine doseA vizsgált kezelés

    Participants will be instructed to smoke their usual brand cigarette as they normally would in weeks 1-2 (Phase I) and to use only the SREC (with or without nicotine) in weeks 3-4 (Phase II) and in weeks 5-6 (Phase III). Participant assignment to SREC type at Phases II and III will be counter-balanced within group, with half of men and women receiving the placebo SREC during Phase II and half during Phase III. Participants will attend 4 laboratory visits with study investigators for 3 hours each over 6 weeks of study participation.

    Kezelés: Nicotine Replacement, Questionnaire Administration és Electronic Cigarette

  • E-Cig nicotine dose followed by E-Cig placebo doseA vizsgált kezelés

    Participants will be instructed to smoke their usual brand cigarette as they normally would in weeks 1-2 (Phase I) and to use only the SREC (with or without nicotine) in weeks 3-4 (Phase II) and in weeks 5-6 (Phase III). Participant assignment to SREC type at Phases II and III will be counter-balanced within group, with half of men and women receiving the placebo SREC during Phase II and half during Phase III. Participants will attend 4 laboratory visits with study investigators for 3 hours each over 6 weeks of study participation.

    Kezelés: Nicotine Replacement, Questionnaire Administration és Electronic Cigarette

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Gender Differences in Standardized Research E-Cigarette (SREC) Product Use, Acceptability, Reinforcement, and Nicotine Dependence Symptoms
Publikációk
A regiszteradat frissítve
2026. január 28.